Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study

Published:2016-02-05 Issue:3 Volume:97 Page:303-309
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Sørrig Rasmus¹²,Klausen Tobias W.³,Salomo Morten¹,Vangsted Annette J.¹,Østergaard Brian⁴,Gregersen Henrik⁵,Frølund Ulf Christian⁶,Andersen Niels F.⁷,Helleberg Carsten⁸,Andersen Kristian T.⁹,Pedersen Robert S.¹⁰,Pedersen Per¹¹,Abildgaard Niels⁴,Gimsing Peter¹,

Affiliation:

1. Department of Hematology; Rigshospitalet; Copenhagen Denmark

2. Department of Clinical Medicine; Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark

3. Hematological Research Laboratory; Herlev Hospital; Herlev Denmark

4. Department of Hematology; Odense University Hospital; Odense Denmark

5. Department of Hematology; Aalborg University Hospital; Aalborg Denmark

6. Department of Hematology; Roskilde Hospital; Roskilde Denmark

7. Department of Hematology; Aarhus University Hospital; Aarhus Denmark

8. Department of Hematology; Herlev Hospital; Herlev Denmark

9. Department of Internal Medicine; Hematological Section; Vejle Hospital; Vejle Denmark

10. Department of Internal Medicine; Hematological section; Holstebro Hospital; Holstebro Denmark

11. Department of Hematology; Esbjerg Hospital; Esbjerg Denmark

Funder

University of Copenhagen Graduate School of Health and Medical Sciences

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12728/fullpdf

Reference19 articles.

1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014

2. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management;Kyle;Leukemi,2010

3. Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma;Mateos;N Engl J Med,2013

4. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells;Pérez-Persona;Blood,2007

5. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma;Dispenzieri;Blood,2008

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma cell disorders supress mucosal anti-bacterial immunity: another dimension of immunoparesis in plasma cell neoplasms;Leukemia;2024-09-07

2. Immunoparesis Recovery in Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients, an Independent Prognostic Factor That Complements Minimal Residual Disease;2024-09-02

3. The impact of biomarkers of malignancy (IMWG SLiM criteria) in myeloma in a real‐world population: Clinical characteristics, therapy and outcomes from the Australian and New Zealand Myeloma and Related Diseases Registry (ANZ MRDR);British Journal of Haematology;2024-07-04

4. Screening in Multiple Myeloma and Its Precursors: Are We There Yet?;Clinical Chemistry;2024-01

5. Clinician preferences on treatment of smoldering myeloma: a cross-sectional survey;eClinicalMedicine;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3